APCR

(redirected from Activated protein C resistance)
Also found in: Medical, Wikipedia.
AcronymDefinition
APCRActivated Protein C Resistance
APCRAir Pollution Control Residue
APCRArmor Piercing Composite Rigid
APCRAssociation pour la Catéchèse en Rural (French: Association for Rural Catechism)
APCRAnalysis, Prompting, Checking, and Reporting
APCRActivate PDP (Packet Data Protocol) Context Request
APCRAssociation Pêche Côtière du Roussillon (French: Coastal Fisheries Association of Roussillon; Roussillon, France)
APCRAnchored Polymerase Chain Reaction (genetics)
APCRAssociation de la Presse Catholique Régionale (French: Regional Catholic Press Association)
APCRAsymmetric Polymerase Chain Reaction (hematology)
References in periodicals archive ?
The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance. Am J Clin Pathol.
Modified test for activated protein C resistance. Lancet.
The discovery of activated protein C resistance. J Thromb Haemost 2003 Jan; 1(1):3-9.
Today, IL offers a comprehensive line of HemosIL reagents for the diagnosis of thrombophilia, including antithrombin, protein C, protein S, activated protein C resistance, factor V Leiden, homocysteine, ThromboPath, and Xpert HemosIL FII & FV molecular.
Activated protein C resistance (FV Leiden) and thrombosis: factor V mutations causing hypercoagulable states.
Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome.
Activated protein C resistance phenotype in patients with antiphospholipid antibodies.
Activated protein C resistance is typically assessed by mixing patient plasma with factor V-deficient plasma.
Table 1 Genetic causes of venous thrombosis Common Activated protein C resistance (APCR)/ Factor V Leiden Prothrombin 20210 mutation Methylenetetrahydrofolate reductase gene mutation Increased factor VIII activity Rare Deficiencies of antithrombin and proteins C and S Very Rare Dysfibrinogenemia Table 2 Acquired conditions affecting functional hypercoagulability test results Antithrombin Decreased in heparin use, recent thrombosis, liver disease, DIC, (1) nephrotic syndrome APCR First generation assays: High factor VIII level, LA, (2) acute phase response Second generation assays: Strong LA, (2) pregnancy Factor VIII Elevated in acute phase reaction; falsely decreased in the presence of LA (2) Homocysteine Elevated in recent thrombosis.
Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance. Br J Haematol 1996;95:550-3.
Evaluation of a tissue factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance. Br J Haematol 1996;95:550-3.
Full browser ?